Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 37%
Hold 21%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is poised for continued growth due to its strong management team, impressive financial performance, and strategic acquisitions in the growing healthcare market. The company has a solid financial position with strong cash flow generation, which supports its ongoing investment and expansion plans. Furthermore, HCA has a strong competitive positioning, attractive clinical quality metrics, and solid expense control, which should contribute to its sustained success.

Bears say

HCA Healthcare is likely to face challenges in the near future due to lower patient collections from Silver plan members and continued bad debt expenses, leading to decreased profits. Admissions growth may be impacted by macro and local market factors, higher wage costs, and changes in reimbursement policies. The company may also face negative headlines and potential investigational risks in the highly regulated healthcare industry. Despite reaffirmed earnings guidance and some improvements in Q1 results, challenges such as flu and weather-related impacts and declines in HIX admissions could affect future financials, leading to a negative outlook on the stock.

HCA Healthcare (HCA) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 19 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $523.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $523.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.